News and features
Read the latest news and features about our world-leading research, discoveries, fundraising and philanthropy. If you want to keep updated on our news, you can follow us on social media or sign up for our Search newsletter.
If you’re a journalist and want to find out more, you can contact our media relations team.
New ‘super-resolution’ MRI could help plan radiotherapy treatment for lung cancer
Researchers have developed a new technique to create high-quality 3D movies of tissues in the body as they move, which could help doctors plan radiotherapy treatment for cancers including lung tumours.
Scientists uncover DNA ‘shield’ with crucial roles in normal cell division, the immune system and cancer
Scientists have made a major discovery about how cells repair broken strands of DNA that could have huge implications for the treatment of cancer.
ICR part of major MedTech commercialisation programme
The ICR is taking part in a major new initiative to drive forward world-class university commercialisation across the country, and encourage collaboration between higher education institutions.
Tiny changes in prostate cancer blood test could spot early warning signs of treatment not working
A test that can detect trace levels of tumour cells in the blood could help spot early signs of treatment not working for men with advanced prostate cancer.
ICR holds first networking event for scientists and commercial partners
The ICR’s Enterprise Unit has hosted our first ever event for our scientists to meet with possible future partners from the commercial sector.
ICR celebrates a new generation of cancer researchers
The ICR award ceremony took place yesterday, to celebrate the hard work and achievements of our 2018 student graduates – and future generation of cancer researchers.
Broadcaster Victoria Derbyshire and former Cancer Research UK CEO Sir Harpal Kumar awarded honorary doctorates
The ICR has invited three individuals to receive Honorary Degrees to recognise and celebrate their dedication and outstanding achievements in cancer research and awareness.
ICR features in prestigious report on university-business collaboration
A new strategic partnership between The ICR, the pharma company Merck and Cancer Research UK features in a new report on effective collaborations between academics and industry partners.
New ‘triple therapy’ could boost treatment and prevent relapse of advanced breast cancer
Treating advanced breast cancer with three drugs instead of one could boost the effectiveness of treatment and stop tumours developing resistance, a new study reports.
Teamwork between cells fuels aggressive childhood brain tumour
Scientists have discovered that cancerous cells in an aggressive type of childhood brain tumour work together to infiltrate the brain, and this finding could ultimately lead to much needed new treatments, according to a new study.
Immunotherapy drug for skin disease could boost hormone treatment for prostate cancer
A new form of immunotherapy reactivates the response to hormone treatment in advanced prostate cancer, a study in mice and human prostate cancer cells has found.
ICR and partners take centre stage at major international conferences
Clinical trials of promising cancer treatments discovered or developed at the ICR were among the highlights at this year’s American Society of Clinical Oncology (ASCO) meeting, the biggest international clinical cancer research gathering of the year.
